<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02539641</url>
  </required_header>
  <id_info>
    <org_study_id>NL50111.091.14</org_study_id>
    <nct_id>NCT02539641</nct_id>
  </id_info>
  <brief_title>Bariatric Procedures and Changes in Incretins and Gastric Emptying</brief_title>
  <acronym>BIG</acronym>
  <official_title>Bariatric Procedures and Changes in Incretins and Gastric Emptying</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rijnstate Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rijnstate Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study evaluates the gastric emptying by scintigraphy in patients that had bariatric
      surgery (RYGB of gastric sleeve) comparing patients with successful and unsuccessful weight
      loss and in patients before and after the placement of a duodenal-jejunal bypass liner.

      Additional, after bariatric surgery gut hormones that influence the gastric emptying rate are
      determined.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Bariatric surgery reduces stomach volume and passage of foods through the gastrointestinal
      tract is altered. The satiety level often increases, which is probably caused by gut
      hormones. Patients response on different bariatric procedures varies widely and it is
      difficult to predict which patient responds well. Possibly, patients who have successful
      excess weight loss (EWL) two years after surgery have different gastric emptying rates
      compared to unsuccessful patients.

      Changes in gut hormones after implantation of a duodenal-jejunal bypass liner were
      demonstrated in other studies. However, gastric emptying before and after placement of this
      liner is unknown.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2015</start_date>
  <completion_date type="Actual">May 2016</completion_date>
  <primary_completion_date type="Actual">September 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Gastric emptying rate after bariatric surgery</measure>
    <time_frame>2 years after surgery</time_frame>
    <description>In the RYGB and SG group</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in gastric emptying rate after implantation of DJBL</measure>
    <time_frame>before and 1 month after</time_frame>
    <description>In the DJBL group</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Gut hormone levels after standard meal</measure>
    <time_frame>2 years after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Weight loss after bariatric surgery</measure>
    <time_frame>2 years after bariatric surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life (SF-36, BAROS) after bariatric surgery</measure>
    <time_frame>2 years after bariatric surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in quality of life (SF-36, BAROS) after DJBL</measure>
    <time_frame>Before and 1 month after implantation of DJBL</time_frame>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Actual">32</enrollment>
  <condition>Morbid Obesity</condition>
  <arm_group>
    <arm_group_label>Good responder RYGB</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Good responders after Roux-en-Y gastric bypass (RYGB). EWL &gt; 50%. Interventions: Gastric emptying scintigraphy and Determination of gut hormones.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bad responder RYGB</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Bad responders after Roux-en-Y gastric bypass (RYGB). EWL &lt; 50% Interventions: Gastric emptying scintigraphy and Determination of gut hormones.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Good responder SG</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Good responders after sleeve gastrectomy (SG). EWL &gt; 50% Interventions: Gastric emptying scintigraphy and Determination of gut hormones.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bad responder SG</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Bad responders after sleeve gastrectomy (SG). EWL &lt; 50% Interventions: Gastric emptying scintigraphy and Determination of gut hormones.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Duodenal-jejunal bypass liner</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patients who will have a duodenal-jejunal bypass liner (DJBL) Intervention: Gastric emptying scintigraphy before and after implantation of DJBL</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Gastric emptying scintigraphy</intervention_name>
    <description>Scintigraphy is performed to evaluate gastric emptying after eating a pancake labeled by 20 megabecquerel (MBq) Technetium-99m-Albumin (TC-99m-LyoMAA)</description>
    <arm_group_label>Good responder RYGB</arm_group_label>
    <arm_group_label>Bad responder RYGB</arm_group_label>
    <arm_group_label>Good responder SG</arm_group_label>
    <arm_group_label>Bad responder SG</arm_group_label>
    <arm_group_label>Duodenal-jejunal bypass liner</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Determination of gut hormones</intervention_name>
    <description>Gut hormone levels will be determined after eating a standard meal in the RYGB and SG groups.</description>
    <arm_group_label>Good responder RYGB</arm_group_label>
    <arm_group_label>Bad responder RYGB</arm_group_label>
    <arm_group_label>Good responder SG</arm_group_label>
    <arm_group_label>Bad responder SG</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients must be able to adhere to the study visit schedule and protocol requirements

          -  Patients must be able to give informed consent and the consent must be obtained prior
             to any study procedures

          -  Patients who had a follow-up period up till 2 years after bariatric surgery without
             any complications or

          -  Patients are eligible for DJBL implantation

        Exclusion Criteria:

          -  Binge-eating or associated eating disorder

          -  Active drug or alcohol addiction

          -  Pregnancy or giving breast feeding

          -  Gluten allergy

          -  Inability to stop medication that affects the motility of the upper GI tract
             (anti-cholinergic drugs, prokinetics, theophylline, calcium blocking agents, opioids)

          -  Endocrine disease influencing gastric emptying (diabetes mellitus, hyper- or
             hypothyroidism). Type 2 diabetes mellitus is not an exclusion criterium for patients
             receiving the DJBL.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Frits J Berends, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rijnstate Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Rijnstate hospital</name>
      <address>
        <city>Arnhem</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <reference>
    <citation>Gersin KS, Keller JE, Stefanidis D, Simms CS, Abraham DD, Deal SE, Kuwada TS, Heniford BT. Duodenal- jejunal bypass sleeve: a totally endoscopic device for the treatment of morbid obesity. Surg Innov. 2007 Dec;14(4):275-8. doi: 10.1177/1553350607312901.</citation>
    <PMID>18178916</PMID>
  </reference>
  <reference>
    <citation>de Moura EG, Orso IR, Martins BC, Lopes GS, de Oliveira SL, Galvão-Neto Mdos P, Mancini MC, Santo MA, Sakai P, Ramos AC, Garrido-Júnior AB, Halpern A, Cecconello I. Improvement of insulin resistance and reduction of cardiovascular risk among obese patients with type 2 diabetes with the duodenojejunal bypass liner. Obes Surg. 2011 Jul;21(7):941-7. doi: 10.1007/s11695-011-0387-0.</citation>
    <PMID>21442376</PMID>
  </reference>
  <reference>
    <citation>de Jonge C, Rensen SS, Verdam FJ, Vincent RP, Bloom SR, Buurman WA, le Roux CW, Schaper NC, Bouvy ND, Greve JW. Endoscopic duodenal-jejunal bypass liner rapidly improves type 2 diabetes. Obes Surg. 2013 Sep;23(9):1354-60. doi: 10.1007/s11695-013-0921-3.</citation>
    <PMID>23526068</PMID>
  </reference>
  <reference>
    <citation>Wang G, Agenor K, Pizot J, Kotler DP, Harel Y, Van Der Schueren BJ, Quercia I, McGinty J, Laferrère B. Accelerated gastric emptying but no carbohydrate malabsorption 1 year after gastric bypass surgery (GBP). Obes Surg. 2012 Aug;22(8):1263-7. doi: 10.1007/s11695-012-0656-6. Erratum in: Obes Surg. 2013 Jul;23(7):1016.</citation>
    <PMID>22527599</PMID>
  </reference>
  <reference>
    <citation>Dirksen C, Damgaard M, Bojsen-Møller KN, Jørgensen NB, Kielgast U, Jacobsen SH, Naver LS, Worm D, Holst JJ, Madsbad S, Hansen DL, Madsen JL. Fast pouch emptying, delayed small intestinal transit, and exaggerated gut hormone responses after Roux-en-Y gastric bypass. Neurogastroenterol Motil. 2013 Apr;25(4):346-e255. doi: 10.1111/nmo.12087. Epub 2013 Jan 29.</citation>
    <PMID>23360316</PMID>
  </reference>
  <reference>
    <citation>Braghetto I, Davanzo C, Korn O, Csendes A, Valladares H, Herrera E, Gonzalez P, Papapietro K. Scintigraphic evaluation of gastric emptying in obese patients submitted to sleeve gastrectomy compared to normal subjects. Obes Surg. 2009 Nov;19(11):1515-21. doi: 10.1007/s11695-009-9954-z. Epub 2009 Aug 28.</citation>
    <PMID>19714384</PMID>
  </reference>
  <reference>
    <citation>Melissas J, Daskalakis M, Koukouraki S, Askoxylakis I, Metaxari M, Dimitriadis E, Stathaki M, Papadakis JA. Sleeve gastrectomy-a &quot;food limiting&quot; operation. Obes Surg. 2008 Oct;18(10):1251-6. doi: 10.1007/s11695-008-9634-4. Epub 2008 Jul 29.</citation>
    <PMID>18663545</PMID>
  </reference>
  <reference>
    <citation>Baumann T, Kuesters S, Grueneberger J, Marjanovic G, Zimmermann L, Schaefer AO, Hopt UT, Langer M, Karcz WK. Time-resolved MRI after ingestion of liquids reveals motility changes after laparoscopic sleeve gastrectomy--preliminary results. Obes Surg. 2011 Jan;21(1):95-101. doi: 10.1007/s11695-010-0317-6.</citation>
    <PMID>21088924</PMID>
  </reference>
  <reference>
    <citation>Escalona A, Yáñez R, Pimentel F, Galvao M, Ramos AC, Turiel D, Boza C, Awruch D, Gersin K, Ibáñez L. Initial human experience with restrictive duodenal-jejunal bypass liner for treatment of morbid obesity. Surg Obes Relat Dis. 2010 Mar 4;6(2):126-31. doi: 10.1016/j.soard.2009.12.009. Epub 2010 Jan 20.</citation>
    <PMID>20359665</PMID>
  </reference>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 20, 2015</study_first_submitted>
  <study_first_submitted_qc>August 31, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 3, 2015</study_first_posted>
  <last_update_submitted>March 27, 2017</last_update_submitted>
  <last_update_submitted_qc>March 27, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 28, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity, Morbid</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hormones</mesh_term>
    <mesh_term>Incretins</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

